Proteome alterations associated with transformation of multiple myeloma to secondary plasma cell leukemia

Plasma cell leukemia is a rare and aggressive plasma cell neoplasm that may either originate de novo (primary PCL) or by leukemic transformation of multiple myeloma (MM) to secondary PCL (sPCL). The prognosis of sPCL is very poor, and currently no standard treatment is available due to lack of prosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zatula, Alexey, Dikic, Aida, Mulder, Celine, Sharma, Animesh, Vågbø, Cathrine B., Sousa, Mirta M.L., Waage, Anders, Slupphaug, Geir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386695/
https://www.ncbi.nlm.nih.gov/pubmed/28038447
http://dx.doi.org/10.18632/oncotarget.14294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5386695/
https://www.ncbi.nlm.nih.gov/pubmed/28038447
http://dx.doi.org/10.18632/oncotarget.14294

Ejemplares similares